IL1R1 and breast cancer: Indeed, IL-1β is considered as a master cytokine in the progression of breast cancer as its production has been found correlated with advanced diseases, whereas the IL1R1 inhibition by the antagonist anakinra was shown to prevent the growth of breast cancer and the bone metastasis in mouse models [25, 37, 42, 76, 77].